Filtered By:
Source: Journal of Drugs in Dermatology
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 904 results found since Jan 2013.
Neurogenic Rosacea Treatment: A Literature Review
J Drugs Dermatol. 2023 Jun 1;22(6):566-575. doi: 10.36849/JDD.7181.ABSTRACTRosacea is a chronic skin disorder involving central facial erythema secondary to vascular instability and cutaneous inflammation. Rosacea is divided into different subtypes based on the morphology of the rash — erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea. A less-known subtype called neurogenic rosacea has been proposed to categorize patients suffering from rosacea with erythematous flushing and burning sensation that is refractory to traditional treatment. There is minimal data on this subgroup of rosacea patie...
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Mirjana G Ivanic Aislyn Oulee Alexandra Norden Sogol S Javadi Michael H Gold Jashin J Wu Source Type: research
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel
CONCLUSION: Choosing a biologic medication for psoriasis often relies on patient preference, provider preference, and a trial-and-error approach. Utilizing precision medicine tests such as Mind.Px can help providers identify biomarkers unique to a patient’s pathophysiology and choose the optimal medication through a targeted and evidence-based approach. Zakria D, Brownstone N, Armstrong AW, et al. Integrating precision medicine into medical dermatology clinical practice: an expert consensus panel. J Drugs Dermatol. 2023;22(6):588-593. doi:10.36849/JDD.7432.PMID:37276166 | DOI:10.36849/JDD.7432
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Danny Zakria Nicholas Brownstone April W Armstrong Erin E Boh John Y M Koo Joseph F Merola David Pariser Mark Lebwohl Source Type: research
Neurogenic Rosacea Treatment: A Literature Review
J Drugs Dermatol. 2023 Jun 1;22(6):566-575. doi: 10.36849/JDD.7181.ABSTRACTRosacea is a chronic skin disorder involving central facial erythema secondary to vascular instability and cutaneous inflammation. Rosacea is divided into different subtypes based on the morphology of the rash — erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea. A less-known subtype called neurogenic rosacea has been proposed to categorize patients suffering from rosacea with erythematous flushing and burning sensation that is refractory to traditional treatment. There is minimal data on this subgroup of rosacea patie...
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Mirjana G Ivanic Aislyn Oulee Alexandra Norden Sogol S Javadi Michael H Gold Jashin J Wu Source Type: research
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel
CONCLUSION: Choosing a biologic medication for psoriasis often relies on patient preference, provider preference, and a trial-and-error approach. Utilizing precision medicine tests such as Mind.Px can help providers identify biomarkers unique to a patient’s pathophysiology and choose the optimal medication through a targeted and evidence-based approach. Zakria D, Brownstone N, Armstrong AW, et al. Integrating precision medicine into medical dermatology clinical practice: an expert consensus panel. J Drugs Dermatol. 2023;22(6):588-593. doi:10.36849/JDD.7432.PMID:37276166 | DOI:10.36849/JDD.7432
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Danny Zakria Nicholas Brownstone April W Armstrong Erin E Boh John Y M Koo Joseph F Merola David Pariser Mark Lebwohl Source Type: research
Neurogenic Rosacea Treatment: A Literature Review
J Drugs Dermatol. 2023 Jun 1;22(6):566-575. doi: 10.36849/JDD.7181.ABSTRACTRosacea is a chronic skin disorder involving central facial erythema secondary to vascular instability and cutaneous inflammation. Rosacea is divided into different subtypes based on the morphology of the rash — erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea. A less-known subtype called neurogenic rosacea has been proposed to categorize patients suffering from rosacea with erythematous flushing and burning sensation that is refractory to traditional treatment. There is minimal data on this subgroup of rosacea patie...
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Mirjana G Ivanic Aislyn Oulee Alexandra Norden Sogol S Javadi Michael H Gold Jashin J Wu Source Type: research
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel
CONCLUSION: Choosing a biologic medication for psoriasis often relies on patient preference, provider preference, and a trial-and-error approach. Utilizing precision medicine tests such as Mind.Px can help providers identify biomarkers unique to a patient’s pathophysiology and choose the optimal medication through a targeted and evidence-based approach. Zakria D, Brownstone N, Armstrong AW, et al. Integrating precision medicine into medical dermatology clinical practice: an expert consensus panel. J Drugs Dermatol. 2023;22(6):588-593. doi:10.36849/JDD.7432.PMID:37276166 | DOI:10.36849/JDD.7432
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Danny Zakria Nicholas Brownstone April W Armstrong Erin E Boh John Y M Koo Joseph F Merola David Pariser Mark Lebwohl Source Type: research
Neurogenic Rosacea Treatment: A Literature Review
J Drugs Dermatol. 2023 Jun 1;22(6):566-575. doi: 10.36849/JDD.7181.ABSTRACTRosacea is a chronic skin disorder involving central facial erythema secondary to vascular instability and cutaneous inflammation. Rosacea is divided into different subtypes based on the morphology of the rash — erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea. A less-known subtype called neurogenic rosacea has been proposed to categorize patients suffering from rosacea with erythematous flushing and burning sensation that is refractory to traditional treatment. There is minimal data on this subgroup of rosacea patie...
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Mirjana G Ivanic Aislyn Oulee Alexandra Norden Sogol S Javadi Michael H Gold Jashin J Wu Source Type: research
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel
CONCLUSION: Choosing a biologic medication for psoriasis often relies on patient preference, provider preference, and a trial-and-error approach. Utilizing precision medicine tests such as Mind.Px can help providers identify biomarkers unique to a patient’s pathophysiology and choose the optimal medication through a targeted and evidence-based approach. Zakria D, Brownstone N, Armstrong AW, et al. Integrating precision medicine into medical dermatology clinical practice: an expert consensus panel. J Drugs Dermatol. 2023;22(6):588-593. doi:10.36849/JDD.7432.PMID:37276166 | DOI:10.36849/JDD.7432
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Danny Zakria Nicholas Brownstone April W Armstrong Erin E Boh John Y M Koo Joseph F Merola David Pariser Mark Lebwohl Source Type: research
Neurogenic Rosacea Treatment: A Literature Review
J Drugs Dermatol. 2023 Jun 1;22(6):566-575. doi: 10.36849/JDD.7181.ABSTRACTRosacea is a chronic skin disorder involving central facial erythema secondary to vascular instability and cutaneous inflammation. Rosacea is divided into different subtypes based on the morphology of the rash — erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea. A less-known subtype called neurogenic rosacea has been proposed to categorize patients suffering from rosacea with erythematous flushing and burning sensation that is refractory to traditional treatment. There is minimal data on this subgroup of rosacea patie...
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Mirjana G Ivanic Aislyn Oulee Alexandra Norden Sogol S Javadi Michael H Gold Jashin J Wu Source Type: research
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel
CONCLUSION: Choosing a biologic medication for psoriasis often relies on patient preference, provider preference, and a trial-and-error approach. Utilizing precision medicine tests such as Mind.Px can help providers identify biomarkers unique to a patient’s pathophysiology and choose the optimal medication through a targeted and evidence-based approach. Zakria D, Brownstone N, Armstrong AW, et al. Integrating precision medicine into medical dermatology clinical practice: an expert consensus panel. J Drugs Dermatol. 2023;22(6):588-593. doi:10.36849/JDD.7432.PMID:37276166 | DOI:10.36849/JDD.7432
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Danny Zakria Nicholas Brownstone April W Armstrong Erin E Boh John Y M Koo Joseph F Merola David Pariser Mark Lebwohl Source Type: research
Neurogenic Rosacea Treatment: A Literature Review
J Drugs Dermatol. 2023 Jun 1;22(6):566-575. doi: 10.36849/JDD.7181.ABSTRACTRosacea is a chronic skin disorder involving central facial erythema secondary to vascular instability and cutaneous inflammation. Rosacea is divided into different subtypes based on the morphology of the rash — erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea. A less-known subtype called neurogenic rosacea has been proposed to categorize patients suffering from rosacea with erythematous flushing and burning sensation that is refractory to traditional treatment. There is minimal data on this subgroup of rosacea patie...
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Mirjana G Ivanic Aislyn Oulee Alexandra Norden Sogol S Javadi Michael H Gold Jashin J Wu Source Type: research
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel
CONCLUSION: Choosing a biologic medication for psoriasis often relies on patient preference, provider preference, and a trial-and-error approach. Utilizing precision medicine tests such as Mind.Px can help providers identify biomarkers unique to a patient’s pathophysiology and choose the optimal medication through a targeted and evidence-based approach. Zakria D, Brownstone N, Armstrong AW, et al. Integrating precision medicine into medical dermatology clinical practice: an expert consensus panel. J Drugs Dermatol. 2023;22(6):588-593. doi:10.36849/JDD.7432.PMID:37276166 | DOI:10.36849/JDD.7432
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Danny Zakria Nicholas Brownstone April W Armstrong Erin E Boh John Y M Koo Joseph F Merola David Pariser Mark Lebwohl Source Type: research
Neurogenic Rosacea Treatment: A Literature Review
J Drugs Dermatol. 2023 Jun 1;22(6):566-575. doi: 10.36849/JDD.7181.ABSTRACTRosacea is a chronic skin disorder involving central facial erythema secondary to vascular instability and cutaneous inflammation. Rosacea is divided into different subtypes based on the morphology of the rash — erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea. A less-known subtype called neurogenic rosacea has been proposed to categorize patients suffering from rosacea with erythematous flushing and burning sensation that is refractory to traditional treatment. There is minimal data on this subgroup of rosacea patie...
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Mirjana G Ivanic Aislyn Oulee Alexandra Norden Sogol S Javadi Michael H Gold Jashin J Wu Source Type: research
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel
CONCLUSION: Choosing a biologic medication for psoriasis often relies on patient preference, provider preference, and a trial-and-error approach. Utilizing precision medicine tests such as Mind.Px can help providers identify biomarkers unique to a patient’s pathophysiology and choose the optimal medication through a targeted and evidence-based approach. Zakria D, Brownstone N, Armstrong AW, et al. Integrating precision medicine into medical dermatology clinical practice: an expert consensus panel. J Drugs Dermatol. 2023;22(6):588-593. doi:10.36849/JDD.7432.PMID:37276166 | DOI:10.36849/JDD.7432
Source: Journal of Drugs in Dermatology - June 5, 2023 Category: Dermatology Authors: Danny Zakria Nicholas Brownstone April W Armstrong Erin E Boh John Y M Koo Joseph F Merola David Pariser Mark Lebwohl Source Type: research
